基于19-24周子宫动脉多普勒风险分层管理子痫前期
这项前瞻性非干预研究纳入96 678例单胎孕妇,在19-24周用竞争风险模型结合母体因素、UtA-PI与MAP预测早产型子痫前期,并据此将人群分为极高、高、中、低风险四级以指导分层产检。
要点
- 19-24周联合母体因素、UtA-PI与MAP筛查对<36周子痫前期预测优于单用UtA-PI。
- 按目标检出约90%早产子痫前期分层,极高危占2.4%、高危3.9%、中危17.8%。
- 20周筛查结果可用于识别需在28和32周额外监测与再评估的孕妇。
核心结论
- 19-24周联合母体因素、UtA-PI MoM与MAP MoM筛查对<28、<32、<36周子痫前期预测优于母体因素联合UtA-PI MoM、UtA-PI固定切点或按孕龄百分位切点。
研究设计与样本
- 前瞻性非干预研究,纳入96 678例单胎孕妇,在19-24周常规产检超声时计算子痫前期风险并分层。
主要发现
- 研究人群中有2866例(3.0%)后续发生子痫前期,其中467例(0.5%)在<36周分娩。
- 以检出约90%的<28、<32、<36周子痫前期为目标,联合母体因素、UtA-PI MoM与MAP MoM筛查时极高危、高危、中危、低危分别占2.4%、3.9%、17.8%、75.9%。
- 母体因素联合UtA-PI MoM筛查时上述四层分别占6.0%、3.0%、21.0%、70.0%。
- UtA-PI固定切点筛查时四层分别占5.7%、7.5%、49.8%、37.0%,按孕龄百分位切点筛查时分别占6.9%、5.2%、49.0%、38.9%。
- 基于母体因素联合UtA-PI与MAP MoM的预测模型校准图显示预测风险与观察发生率一致性良好。
关键数值与推荐
- 所有孕妇应在20周和36周进行子痫前期筛查。
- 20周筛查结果用于识别需要在28周和32周额外监测与再评估的亚组。
临床怎么用
- 可在19-24周用母体因素、UtA-PI与MAP联合评估子痫前期风险,据此将孕妇分为极高、高、中、低危以安排后续监测强度。
- 对20周评估为高风险者,按原文建议在28周和32周再评估。
局限性
- 原文为前瞻性非干预研究,风险分层对临床结局的影响未在干预试验中验证。
- 研究人群为单胎妊娠,未报告多胎或其他人群的适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There were two objectives of this study. First, to examine the value of uterine artery pulsatility index (UtA-PI) at 19-24 weeks' gestation in the prediction of subsequent development of pre-eclampsia (PE) and to compare the performance of screening between the use of, first, fixed cut-offs of UtA-PI, second, percentile cut-offs of UtA-PI adjusted for gestational age, third, a competing-risks model combining maternal demographic characteristics and medical history with UtA-PI, and, fourth, a competing-risks model combining maternal factors with UtA-PI and mean arterial pressure (MAP). Second, to stratify pregnancy care based on the estimated risk of PE at 19-24 weeks' gestation from UtA-PI and combinations of maternal factors with UtA-PI and MAP. METHODS: This was a prospective, non-intervention study in women attending for an ultrasound scan at 19-24 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE at < 36 weeks' gestation were calculated using the competing-risks model to combine the prior distribution of the gestational age at delivery with PE, obtained from maternal characteristics and medical history, with multiples of the median (MoM) values of UtA-PI and MAP. Different risk cut-offs were used to vary the proportion of the population stratified into each risk category (very high risk, high risk, intermediate risk and low risk) with the intention of detecting about 80%, 85%, 90% and 95% of cases of delivery with PE at < 28, < 32 and < 36 weeks' gestation. We also examined the performance of screening by maternal factors and UtA-PI MoM, fixed cut-offs of UtA-PI and percentile cut-offs of UtA-PI adjusted for gestational age. Calibration for risks for PE < 36 weeks' gestation by the combination of maternal factors, UtA-PI MoM and MAP MoM was assessed by plotting the observed incidence of PE against the predicted incidence. Additionally, we developed reference ranges of transabdominal and transvaginal measurement of UtA-PI according to gestational age. RESULTS: In the study population of 96 678 singleton pregnancies, there were 2866 (3.0%) that subsequently developed PE, including 467 (0.5%) that delivered at < 36 weeks' gestation. If the objective of screening was to identify about 90% of cases of delivery with PE at < 28, < 32 and < 36 weeks and the method of screening was a combination of maternal factors, UtA-PI MoM and MAP MoM, the proportion of the population stratified into very high-risk, high-risk, intermediate-risk and low-risk groups would be 2.4%, 3.9%, 17.8% and 75.9%, respectively; the respective values were 6.0%, 3.0%, 21.0% and 70.0% if screening was by maternal factors and UtA-PI MoM, 5.7%, 7.5%, 49.8% and 37.0% if screening was by fixed cut-offs of UtA-PI and 6.9%, 5.2%, 49.0% and 38.9% if screening was by percentile cut-offs of UtA-PI. In the validation of the prediction model based on a combination of maternal factors and MoM values of UtA-PI and MAP, calibration plots demonstrated good agreement between the predicted risk and the observed incidence of PE. CONCLUSIONS: All pregnant women should have screening for PE at 20 and 36 weeks' gestation. The findings at 20 weeks can be used to identify the subgroups that require additional monitoring and reassessment at 28 and 32 weeks. The performance of screening by a combination of maternal factors and MoM values of UtA-PI and MAP at 19-24 weeks for delivery with PE at < 28, < 32 and < 36 weeks' gestation is superior to that of screening by a combination of maternal factors and UtA-PI MoM, by fixed cut-offs of UtA-PI or by percentile cut-offs of UtA-PI. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Litwinska M, Litwinska E, Lisnere K, et al. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation. Ultrasound Obstet Gynecol. 2021. PMID: 33645854. doi:10.1002/uog.23623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。